Pharmaceutical

Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

March 11, 2010

Findings will Contribute to Understanding and Future Study of Figitumumab
 

Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens

March 10, 2010

Premium Lens Provides Medicare Beneficiaries With New Option
 

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

March 09, 2010

Abbott will acquire Facet for $27 per share in cash
 

Lilly to Acquire European Rights to Pfizer Animal Health Assets

March 08, 2010

Deal Provides Strategic Fit For Elanco, Lilly's Animal Health Division
 

Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment

March 03, 2010

Easy to use and simple treatment option for growth hormone disorders
 

Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer

March 01, 2010

Mr. Nida has more than 30 years of pharmaceutical industry experience
 

Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash

March 01, 2010

Astellas to build a world-class oncology platform
 

Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease

February 26, 2010

Company Announces New Enhancements to Patient Assistance Programs in the United States
 

Adamis Pharmaceuticals Signs Agreement to Acquire Prostate Cancer Drug Candidates

February 25, 2010

Adamis to retain U.S. rights and out-license other geographic territories
 

Novartis Receives FDA Approval of Menveo(R), a Vaccine to Prevent Meningococcal Disease

February 22, 2010

Novartis plans to seek licensure of Menveo in infants and children 2-10 years of age
 

Merz to Complete Acquisition of BioForm Medical

February 19, 2010

Creates a Global Leader in Medical Aesthetics
 

Mission Pharmacal Launches New Formulation of Kidney Stone Treatment, Urocit(R)-K 15 mEq

February 17, 2010

Maximum-strength, more convenient option available to help increase patient compliance
 

Javelin Pharmaceuticals' Receives FDA PDUFA Date for Dyloject NDA

February 17, 2010

Filed NDA for Management of Acute Moderate-to-Severe Pain
 

Abbott Completes Acquisition of Solvay Pharmaceuticals

February 16, 2010

Abbott Pays $6.2 Billion for Solvay Pharmaceuticals
 

FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16

February 11, 2010

New Treatment Option Available for the Rapidly Growing Population of Children Suffering From High Blood Pressure
 

Adeona Appoints James S. Kuo, M.D., M.B.A., as Chairman, CEO and President

February 09, 2010

Company Intends to Launch and Establish Corporate Partnerships for Its Products
 

ADVENTRX Announces Management Promotions

February 04, 2010

Brian M. Culley will serve as Chief Executive Officer
 

Noven Appoints Patrick Gallagher as Vice President of Business Development

February 03, 2010

Gallagher has over 25 years' experience in the pharmaceutical, biotechnology and drug delivery industries
 

Labopharm Receives FDA Approval For OLEPTRO(TM)

February 03, 2010

Second U.S. FDA Product Approval in Just Over a Year For Labopharm's CONTRAMID(R) Controlled Release Technology
 

Allergan, Inc. Announces FDA Approval of JUVÉDERM® XC Dermal Filler Formulated with Lidocaine

February 01, 2010

Approved to Last up to One Year from Initial Treatment
 

GSK's TYKERB(R) Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer

January 29, 2010

TYVERB in European markets, is currently being reviewed by the EMEA for a comparable indication
 

QuantRx Biomedical to Acquire NuRx Pharmaceuticals

January 29, 2010

Combination Strengthens Financial and Competitive Position